Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROUTE: LB54640 in Genetic Obesity (POMC, PCSK1, LEPR Deficiency)
NCT06041841Phase 2Not yet recruiting
- Sponsor
- LG Chem
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of LB54640 in obesity, sponsored by LG Chem. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
LB54640
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06041841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06041841.